Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Latigo Biotherapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-112.32	-110.39	-63.45
Net Income	-111.18	-109.17	-61.18

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	42.37	69.63	17.92
Total Debt	0.55	0.69	0.85
Net Cash (Debt)	41.82	68.94	17.07
Net Cash Growth	-	303.93%	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-103.47	-97.56	-50.96
Capital Expenditures	-0.03	-0.14	-0.07
Free Cash Flow	-103.5	-97.69	-51.03
Free Cash Flow Growth	-	-	-